HPLC Method for Separation of Donepezil and 1-Benzylpiperidine-4-carbaldehyde on Primesep 100 Column

HPLC Method for Donepezil, 1-Benzylpiperidine-4-carbaldehyde on Primesep 100 by SIELC Technologies

High Performance Liquid Chromatography (HPLC) Method for Analysis of Donepezil, 1-Benzylpiperidine-4-carbaldehyde

Donepezil is a medication with the chemical formula C24H29NO3. It is primarily used to treat dementia and improve cognition, but has not shown to cause any change in the progression of the disease. Some research suggests that it can be used to treat Lewy body dementia, effects of traumatic brain injury, and vascular dementia. 1-Benzylpiperidine-4-carbaldehyde is an important intermediate used in pharmaceutical and medicinal chemistry research. Its reactive aldehyde group and piperidine ring make it useful for synthesizing biologically active compounds.

You can find detailed UV spectra of Donepezil, 1-Benzylpiperidine-4-carbaldehyde and information about its various lambda maxima by visiting the following link.

Donepezil, 1-Benzylpiperidine-4-carbaldehyde can be retained and analyzed using the Primesep 100 stationary phase column. The analysis utilizes an isocratic method with a simple mobile phase consisting of acetonitrile (MeCN). Detection is performed using UV.

ColumnPrimesep 100, 4.6 x 150 mm, 5 µm, 100 A, dual ended
Mobile PhaseMeCN/H2O – 60/40%
BufferSulfuric Acid – 0.2%
Flow Rate1.0 ml/min
DetectionUV 208 nm
Limit of Detection*1. 16 ppb, 2.0 18 ppb
Class of Compounds
Drug
Analyzing CompoundsDonepezil, 1-Benzylpiperidine-4-carbaldehyde
*LOD was determined for this combination of instrument, method, and analyte, and it can vary from one laboratory to another even when the same general type of analysis is being performed.

Application Column

Primesep 100

Column Diameter: 4.6 mm
Column Length: 150 mm
Particle Size: 5 µm
Pore Size: 100 A
Column options: dual ended

Add to cart
Application Analytes:
1-Benzylpiperidine-4-carbaldehyde
Donepezil

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.